Qingzhen Yu Selected Research

Qingzhen Yu Research Topics

3	Alzheimer Disease (Alzheimer's Disease) 01/2020 - 01/2019
3	Schizophrenia (Dementia Praecox) 01/2020 - 09/2018
2	Neoplasms (Cancer) 01/2023 - 01/2022
2	Fibrosis (Cirrhosis) 01/2022 - 01/2020
2	Adenocarcinoma of Lung 01/2022 - 01/2022
2	Central Nervous System Diseases (CNS Diseases) 01/2022 - 01/2019
2	Liver Cirrhosis (Hepatic Cirrhosis) 01/2022 - 01/2020
2	Substance-Related Disorders (Drug Abuse) 01/2020 - 10/2019
2	Parkinson Disease (Parkinson's Disease) 01/2020 - 01/2019
2	Neurodegenerative Diseases (Neurodegenerative Disease) 10/2019 - 01/2019
1	Acute Promyelocytic Leukemia 01/2023
1	Urinary Bladder Neoplasms (Bladder Cancer) 01/2023
1	Osteoporosis 01/2023
1	Liver Diseases (Liver Disease) 01/2022
1	Insulin Resistance 01/2022
1	Brain Diseases (Brain Disorder) 01/2020
1	Epilepsy (Aura) 09/2018

2	Carbon Tetrachloride (Tetrachloromethane)IBA 01/2022 - 01/2020
2	6-methyladenineIBA 01/2022 - 01/2022
2	Monoacylglycerol LipasesIBA 01/2022 - 10/2019
1	Alendronate (Alendronate Sodium)FDA LinkGeneric 01/2023
1	Zoledronic Acid (Zometa)FDA Link 01/2023
1	Antineoplastic Agents (Antineoplastics)IBA 01/2023
1	ArsenicIBA 01/2023
1	1-dodecylpyridoxal (PLD)IBA 01/2022
1	TARPIBA 01/2022
1	CannabinoidsIBA 01/2022
1	EnzymesIBA 01/2022
1	LigandsIBA 01/2022
1	RNA (Ribonucleic Acid)IBA 01/2022
1	metabotropic glutamate receptor 2IBA 01/2020
1	IntegrinsIBA 01/2020
1	Cholesterol 24-Hydroxylase (CYP46A1)IBA 01/2020
1	Biomarkers (Surrogate Marker)IBA 01/2020
1	Leucine (L-Leucine)FDA Link 01/2019
1	Proteins (Proteins, Gene)FDA Link 01/2019
1	xanomelineIBA 01/2019
1	N-Methyl-D-Aspartate Receptors (NMDA Receptors)IBA 01/2019
1	AMPA Receptors (AMPA Receptor)IBA 09/2018
1	AcidsIBA 09/2018

2	Ligation 01/2022 - 01/2020